Gcn2 inhibitors and uses thereof
US-2025059190-A1 · Feb 20, 2025 · US
Everitt Simon is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Everitt Simon |
| Total patents | 15 |
| First publication | Mar 24, 2015 |
| Latest publication | Feb 20, 2025 |
Publications ranked by popularity score, then publication date.
US-2025059190-A1 · Feb 20, 2025 · US
US-12084438-B2 · Sep 10, 2024 · US
US-2022340577-A1 · Oct 27, 2022 · US
US-10988477-B2 · Apr 27, 2021 · US
US-2021040083-A1 · Feb 11, 2021 · US
US-10793563-B2 · Oct 6, 2020 · US
US-2019233425-A1 · Aug 1, 2019 · US
US-2019233411-A1 · Aug 1, 2019 · US
US-9499497-B2 · Nov 22, 2016 · US
US-2015376187-A1 · Dec 31, 2015 · US
Latest publications not already listed above.
US-2015336903-A1 · Nov 26, 2015 · US
US-9096602-B2 · Aug 4, 2015 · US
US-9073875-B2 · Jul 7, 2015 · US
US-2015152103-A1 · Jun 4, 2015 · US
US-8987454-B2 · Mar 24, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Vertex Pharma | 15 |
| Merck Patent Gmbh | 8 |
| Everitt Simon | 1 |
| Mortimore Michael Paul | 1 |
| Charrier Jean-Damien | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 15 |
| A61P29/00 | 13 |
| A61P9/00 | 10 |
| A61P37/00 | 10 |
| C07D519/00 | 10 |